With voter registration closing Monday night, Texas gears up for a pivotal March primary. East Texas Democrats express cautious optimism about statewide prospects, while Republicans remain confident in their stronghold as key races take shape.
Marius Borg Høiby, the 29-year-old son of Norway's Crown Princess Mette-Marit, stands trial in Oslo on 38 charges including the alleged rape of four women and assaults on former partners, in a case that has shaken the monarchy's public image.
With its patented, FDA-recognized compound Niagen®, Niagen Bioscience (NAGE) has carved out a unique and defensible position at the intersection of nutraceuticals and pharmaceuticals. As the cellular health market expands, the company's dual-channel strategy and deep scientific validation present a compelling growth narrative for investors.
A Democrat's symbolic victory in a Texas Senate district, which Trump won by 17 points, sends shockwaves through Republican strategy to retain the U.S. House, highlighting potential cracks in GOP support among suburban and Hispanic voters.
House Speaker Mike Johnson confronts a fractured Republican conference upon lawmakers' return to Washington, with hardline members demanding contentious policy riders in exchange for votes to end the government shutdown.
Alphabet's autonomous vehicle unit Waymo is reportedly in talks to raise approximately $16 billion in a new financing round, which would value the company close to $110 billion. The move comes as the robotaxi pioneer faces heightened regulatory and public scrutiny following recent incidents involving its vehicles.
As Palantir Technologies reports a massive surge in U.S. government revenue, CEO Alex Karp publicly defends the company's controversial surveillance platforms, insisting they contain safeguards against overreach. The defense comes amidst growing public and political scrutiny over its contracts with immigration enforcement agencies.
Ford Motor and Chinese tech giant Xiaomi have firmly denied a Financial Times report of preliminary talks to collaborate on electric vehicle production in the U.S., even as Ford's CEO publicly admires and studies Chinese EV technology while labeling it a major competitive threat.
Elon Musk merges his space and AI ambitions under one roof as SpaceX finalizes the acquisition of xAI. The strategic move, combining Starlink, social platform X, and chatbot Grok, sets the stage for a landmark public offering and accelerates Musk's vision for off-planet data infrastructure.
York Space Systems (YSS) launched onto the public market with a strong first-day pop, capitalizing on defense spending trends and a push for scalable satellite manufacturing. Yet, its path is fraught with competition and the financial growing pains typical of a capital-intensive industry.
The benchmark index has been trapped in a tight range for months, gaining a mere 1% since October as a defensive rotation into energy and healthcare pressures tech-heavy portfolios. Analysts warn the prolonged consolidation is creating a 'ticking clock' scenario, setting the stage for a decisive breakout or breakdown.
Elon Musk is reportedly in advanced discussions to merge his space exploration giant, SpaceX, with his artificial intelligence venture, xAI, in a move that could reshape the frontiers of both industries and delay SpaceX's anticipated public offering.
Amid surging government revenue and public protests over its ICE contracts, Palantir CEO Alex Karp defends the company's controversial surveillance technology, framing it as a safeguard against state overreach rather than an enabler.
The Hennepin County Medical Examiner has officially classified the January shooting death of ICU nurse Alex Pretti as a homicide, a finding that intensifies legal and public pressure on the federal agents involved amid ongoing protests and disputed official narratives.
New clinical imaging data for Molecular Partners' experimental radiotherapeutic MP0712, targeting the DLL3 protein in cancers like small cell lung cancer, show favorable tumor targeting and healthy organ clearance. The company confirms its U.S. Phase I/II trial is now open for patient screening.
Former Congressman Colin Allred delivers a pointed public rebuke of Texas House member James Talarico, alleging derogatory comments were made during the heated Democratic Senate primary campaign.
As the ASX braces for a turbulent February amid rate hike fears, a closer look reveals resilient micro-caps with unique value propositions. We analyze three sub-$150M companies—from healthcare tech to critical minerals—that are navigating the volatility with strong balance sheets and niche market positions.
Former Iranian President Hassan Rouhani has issued a stark warning to the regime, urging sweeping reforms to address public grievances as internal divisions surface following a deadly crackdown on protests. The rare public criticism from within the establishment highlights growing tensions ahead of renewed nuclear talks.
A federal judge's sharply worded order releasing a detained migrant father and son has ignited a political firestorm, with prominent Republicans demanding impeachment and decrying judicial overreach.
A stunning Democratic victory in a Texas State Senate district, which swung over 30 points from the 2024 presidential results, has triggered urgent warnings from former Trump aide Sean Spicer about Republican turnout and strategy.
